Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.251, 2000-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Capecitabine and bevacizumab set new standards
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
Access to resources
Recommend
The first independent anticoagulation disease management (DM) programme
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. :
"Pioneering" DM programme saves millions in first year
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 423, 2003-01 ,pp. :
New safety reporting standards set for implementation
Reactions Weekly, Vol. 1, Iss. 1435, 2013-01 ,pp. :
Resource use, costs down in first year of DM programme
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. :